Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma

Por Al-Mansour, Zeina, Ramanathan, Muthalagu
Publicado no Adv Hematol (2014)

Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

Por Al-Mansour, Zeina, Nelson, Beverly P., Evens, Andrew M.
Publicado no Curr Hematol Malig Rep (2013)

De novo CD5+ Diffuse Large B-cell Lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multi-center, rituximab treated cohort

Por Alinari, Lapo, Gru, Alejandro, Quinion, Carl, Huang, Ying, Lozanski, Arletta, Lozanski, Gerard, Poston, Jacqueline, Venkataraman, Girish, Oak, Eunhye, Kreisel, Friederike, Park, Steven I., Matthews, Stephanie, Abramson, Jeremy S., Lim, Hana Iris, Martin, Peter, Cohen, Jonathon B., Evens, Andrew, Al-Mansour, Zeina, Singavi, Arun, Fenske, Timothy S., Blum, Kristie A.
Publicado no Am J Hematol (2016)

Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies

Por Costa, Luciano J., Maddocks, Kami, Epperla, Narendranath, Reddy, Nishitha M., Karmali, Reem, Umyarova, Elvira, Bachanova, Veronika, Costa, Cristiana, Glenn, Martha J., Chavez, Julio C., Calzada, Oscar, Lansigan, Frederick, Nasheed, Hossain, Barta, Stefan K., Zhou, Zheng, Jaglal, Michael, Chhabra, Saurabh, Hernandez-Ilizaliturri, Francisco, Xavier, Ana C., Mehta, Amitkumar, Peker, Deniz, Forero-Torres, Andreas, Al-Mansour, Zeina, Evens, Andrew M., Cohen, Jonathon B., Flowers, Christopher R., Fenske, Timothy S., Hamadani, Mehdi
Publicado no Am J Hematol (2017)